basic called glp 1 GLP-1 GLP-1s: What They Are and

Zaffina I, Pelle MC, Armentaro G, Giofr F, Cassano V, Sciacqua A, et al

Conditions being studied Scientists are looking at how GLP1 agonists impact: Progression of diabetic retinopathy , a diabetes-related eye disease that can cause blurriness and blindness While initial studies indicated that diabetic retinopathy could worsen while taking this medication, more recent, large-scale data suggests that there is no increased risk

Rising Global Prevalence of Type 2 Diabetes and Obesity The rising global prevalence of type 2 diabetes and obesity is boosting the need for the GLP-1 receptor agonist, as these conditions represent the primary therapeutic targets for this drug class

Medication can help manage these systems, but long-term success is usually strongest when pharmacological treatment is combined with structured lifestyle support.